Healthcare -
Biotechnology - NASDAQ - US
$ 13.55
0 %
$ 196 M
Market Cap
0.11
P/E
INBX - SHORT-TERM DEBT
Short-term Debt INBX - Inhibrx Biosciences, Inc.
4.13 M
LAST VALUE
57.00%
2 YEAR CAGR
-7.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR